Starting to pay dividends
Betsy and I have worked very hard---and continue to work hard---to educate lymphoma patients of the value of radioimmunotherapy (RIT).
We have urged the non-Hodgkin's lymphoma patient to insist on obtaining a consultation with a radiation oncologist or nuclear medicine physician to learn whether RIT is appropriate for him or her. We have urged that this consultatilon take place before a decision has been made on therapy.
I am pleased to report that, just a few weeks after the RIT meeting that I chaired for physicians and patients, 3 patients are scheduled to receive RIT in the next 2 weeks. Additionally, several others have had appropriate RIT consultatlions and these patients are awaiting test results that will indicate whether RIT is indicated.
This is very good news.
Mort